Portfolio’s Dissemination and communication activities RP1
(se abrirá en una nueva ventana)
The report includes a description of the activities, the outcomes and any planned follow up.
ELSA activities in RP2
(se abrirá en una nueva ventana)
Report on the activities, outcomes and planned follow up to address ethical, legal and social aspects (ELSA). These activities include engagement with strategic partners (including the public), and dissemination of best practices and guidelines when applicablewith the ELMs field. Any confidential information related to these activities will be included in the technical periodic report.
Contribution to the regulatory debate in RP1
(se abrirá en una nueva ventana)
Report on the activities, outcomes and planned follow up to assess and address the ELMs portfolio needs. This includes contribution to the regulatory debate by engaging early on and continuously with regulatory bodies. Any confidential information related to these activities will be included in the technical periodic report.
Plan for Dissemination and exploitation including communication activities
(se abrirá en una nueva ventana)
Deliver a dissemination and exploitation plan including communication activities.
Contribution to the regulatory debate in RP2
(se abrirá en una nueva ventana)
Report on the activities, outcomes and planned follow up to assess and address the ELMs portfolio needs. This includes contribution to the regulatory debate by engaging early on and continuously with regulatory bodies. Any confidential information related to these activities will be included in the technical periodic report.
Strategic definition of the cell types needed
(se abrirá en una nueva ventana)
Based on developmental biology knowhow research we will define the cardiac cell subtypes necessary to better mimic the tissue biology of the human heart.
ELSA activities in RP1.
(se abrirá en una nueva ventana)
Report on the activities, outcomes and planned follow up to address ethical, legal and social aspects (ELSA). These activities include engagement with strategic partners (including the public), and dissemination of best practices and guidelines when applicable with the ELMs field. Any confidential information related to these activities will be included in the technical periodic report.
Portfolio’s Dissemination and communication activities RP2
(se abrirá en una nueva ventana)
The report includes a description of the activities, the outcomes and any planned follow up.
Optimized protocol for upscaling differentiation of cardiac ventricular and atrial cardiomyocytes
(se abrirá en una nueva ventana)
To produce the ELMs we will need millions of cardiac cells, therfore we will optimized protocol for upscaling differentiation of cardiac ventricular and atrial cardiomyocytes in order to have a constant inflow of cells for the project.
